Block & Leviton LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Biogen, Inc. – BIIBBOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Block & Leviton LLP announces that the United States District Court for the District of Massachusetts has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Biogen, Inc. (
NASDAQ: BIIB):
SHAREHOLDER ALERT: Direct Digital Holdings Sued for Securities Fraud by Block & Leviton LLP; July 22 Deadline To Seek To Serve As Lead PlaintiffBOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- On behalf of an individual investor, Block & Leviton LLP filed a class action lawsuit today against Direct Digital Holdings, along with certain individuals, alleging that they violated federal securities laws by issuing false and misleading statements concerning the company’s business, operations, and prospects. A copy of the Complaint is available on Block & Leviton’s website.
SHAREHOLDER ALERT: Oddity Tech Investigated for Securities Fraud Violations by Block & LevitonBOSTON, May 21, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Oddity Tech (Nasdaq: ODD) for potential securities law violations. Investors who have lost money in their Oddity Tech investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/odd.
Altimmune, Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through A Recent Securities LawsuitBOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Block & Leviton announces that a securities fraud lawsuit has been filed against Altimmune, Inc. (Nasdaq: ALT) and certain of its executives. Investors who have lost money in their Altimmune, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/alt.
